A post by @FirstSquawk on X.

Cardinal Health reported first-quarter 2027 adjusted EPS of $3.26, beating the $2.93 estimate, alongside adjusted operating income of $1.0 billion versus $922.9 million expected and revenue of $67.5 billion against a $66.71 billion consensus. The company also raised its full-year adjusted EPS guidance to $12.80–$13.00 from a prior $12.40–$12.60 range. The across-the-board beat and guidance hike signal stronger-than-expected margin performance in its core distribution and medical segments. Investors will watch whether the improved profitability holds through the remainder of the fiscal year and how competitors respond when they report.